Yokota, Tomoya <br/><br/>
Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?  [electronic resource] 

 -  Anti-cancer agents in medicinal chemistry  Feb 2012 
 - 163-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1875-5992 
<br/><br/><label>Standard No.: </label>10.2174/187152012799014968  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biomarkers, Tumor--genetics<br/>Colon--metabolism<br/>Colorectal Neoplasms--diagnosis<br/>Humans<br/>Mutation<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Rectum--metabolism<br/>ras Proteins--genetics